Linda Levi, BSc

  • 2Articles
  • 9.9KReads1
  • 2017–2022Active
  • 21Collaborators
  • 50Citations2

About

Linda Levi, BSc, is affiliated with the Department of Psychiatry at Sheba Medical Center in Tel Hashomer, Israel. Her publications focus on the treatment of schizophrenia and schizoaffective disorders, including clinical trials investigating adjunctive therapies such as pramipexole and raloxifene combined with antipsychotics. Her work has appeared in Psychiatrist.com between 2017 and 2022.

Publications

JCP
Add-on Pramipexole for Schizophrenia
Original Research

Add-on Pramipexole for Schizophrenia

August 1, 2022

Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
, , , et al
JCP
Original Research

Raloxifene in Postmenopausal Women With Schizophrenia

August 23, 2017

The estrogen protection hypothesis of schizophrenia was introduced in the late 1980s to explain  gender-related differences in epidemiology and clinical features. This study examines whether raloxifene, an estrogen agonist,...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe